Peptit CJC-1295

(DAC-GRF) is a synthetic and modified analogue of endogenous peptide hormone called growth hormone releasing hormone (GHRH, somatocrine).

CJC-1295 significantly increases plasma growth hormone and IGF-1 (insulin-like growth factor 1) levels in the body and is one of the most effective peptides for growth hormone optimization.

CJC-1295 stimulates gh production and binding to the free ghrh receptor (GHRHR) on anterior pituitary cells, and can be combined (stacked) very well with other HR peptides (GHRP-6, Ipamorelin, etc.) for its synergistic effect. CJC-1295

CHEMICAL STRUCTURE CJC

The chemical structure of the -1295 molecule includes the arrangement of atoms and the chemical bonds that hold the atoms together.

CJC 1295 molecule contains a total of 492 bond(s),

240 non-H bond(s), 55 multiple bond(s),

118 rotatable bond(s), 37 double bond(s),

18 aromatic bond(s),

3 six-membered ring (s),

2 carboxylic acid(s) (aliphatic),

4 primary stomach(s) (aliphatic),

28 secondary amide(s) (aliphatic),

3 guanidine derivative(s),

6 primary amine(s) (aliphatic) ,

3 secondary amine(s) (aliphatic),

6 hydroxyl group(s),

2 aromatic hydroxyl(s),

3 primary alcohol(s) and 1 secondary alcoho

Growth hormone releasing hormone (GHRH) has been modified a number of times to produce analogues that preserve some of the hormone's effects while eliminating others. One of those modifications,

CJC-1295, consists of just the first 29 amino acids of GHRH. This analogue of GHRH, which is technically a maleimido derivative of GRF 1-29 hGRF(1-29),

was created in an effort to produce a more soluble GH secretagogue that is easier to produce in large quantities but still preserves the physiologic actions of GHRH.